Chief, Center for HIV, Hepatitis, STD, and TB Epidemiology, Rhode Island Department of Health.
Communication Manager, Division of Emergency Preparedness and Infectious Disease, Rhode Island Department of Health.
R I Med J (2013). 2024 Dec 2;107(12):27-29.
Since 2022, mpox (formerly known as monkeypox) has emerged as a sexually-associated infection that disproportionately impacts gay, bisexual, and other men who have sex with men (GBMSM). Fortunately, the JYNNEOS vaccine, which was initially developed for smallpox, has demonstrated significant efficacy against mpox and was distributed across the United States. In January 2024, the Centers for Disease Control and Prevention (CDC) reported that Rhode Island ranked first among the 50 states for rates of full vaccination coverage (two doses) against mpox among people at increased risk including GBMSM, and second among the 50 states for rates of partial vaccination (single dose).1 The Rhode Island Department of Health (RIDOH), in partnership with other state agencies, clinicians, and community-based organizations, succeeded in rapid outbreak response focusing on community engagement and health equity to address the mpox epidemic.
自 2022 年以来，猴痘（以前称为猴痘）已成为一种与性传播相关的感染， disproportionately 影响男同性恋、双性恋和其他与男性发生性关系的男性（GBMSM）。幸运的是，最初为天花开发的 JYNNEOS 疫苗对猴痘具有显著疗效，并在美国各地分发。2024 年 1 月，疾病控制与预防中心（CDC）报告称，罗得岛在 50 个州中，针对包括 GBMSM 在内的高危人群的 mpox 完全疫苗接种（两剂）覆盖率方面排名第一，在 50 个州中，部分疫苗接种（一剂）率排名第二。1 罗得岛州卫生厅（RIDOH）与其他州机构、临床医生和社区组织合作，成功地快速应对疫情，重点是社区参与和健康公平，以解决猴痘疫情。
